Cesarean Scar Defect: a Prospective, Observational Study.

Condition(s) studied

Investigational drug(s) / intervention(s)

Transvaginal ultrasonography examination: Transvaginal ultrasonography examination to assess the uterine measurements, residual myometrium thickness, adjacent myometrium thickness, niche depth, niche width, uterine cervix to cesarean section scar distance. Gynecological examination including pelvic organ prolapse examination, cough test.

Study summary

The study is conducted as part of the doctoral thesis of Natalia Mazur-Ejankowska, a medical doctor undergoing specialist training in obstetrics and gynecology at the Department of Obstetrics and Gynecology, Gynecologic Oncology, and Gynecologic Endocrinology at the University Clinical Centre in Gdańsk, Poland, where the research will be carried out at every stage.

The aim of the study is to evaluate the cesarean section scar and the lower uterine segment after first cesarean section, and to assess risk factors, symptoms, and epidemiological data in patients enrolled to the study.

Eligibility

Primary outcome measure(s)

• Transvaginal ultrasonography: uterine cesarean section scar assessment. — Transvaginal ultrasonography assessment of the uterine cesarean section scar will be performed 6 months after cesarean section.
  Transvaginal ultrasonography assessment: uterus measurements, residual and adjacent myometrium thickness, niche depth and width, uterine cervix to cesarean section scar distance.

Trial sites (1)

More Medical University of Gdansk trials in Poland